# BRIXADI

NDC: 58284-232
Generic name: BUPRENORPHINE
Labeler / Manufacturer: Braeburn Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20230606

FDA application: NDA210136

## Active ingredients

- BUPRENORPHINE: 32 mg/.64mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58284-232"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58284-232
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d8a8fd0-8619-422a-a664-d1d2e8970f48